
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Avivo, a British Columbia-based preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a persons blood group to group O, the universal donor type. This innovative platform enables a world where a persons blood type is no longer the first constraint when they need life-saving organ transplants or blood transfusions. Avivos platform will enable healthcare providers to better prioritize patients by medical urgency, spend less on management and logistics and ultimately save more lives
Enzymes,blood transfusion,organ transplantation,universal donor blood,and universal donor organs
Avivo biomedical inc operates in the Biotechnology industry.
Avivo biomedical inc's revenue is 11m - 100m
Avivo biomedical inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.